Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.

Transplantation proceedings - 1 Aug 1990

Chatenoud L, Ferran C, Legendre C, Kurrle R, Kreis H, Bach J F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anti-Idiotypic
Share to Antibodies, Monoclonal
Share to Enzyme-Linked Immunosorbent Assay
Share to Immunosuppression Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Transplantation

Share to Receptors, Antigen, T-Cell

Share to Transplantation, Homologous

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 2117809

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.PMID 2117809Read ↗

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.Semantic proximity Read ↗

Ultra-late antibody-mediated rejection 30 years after a living-related renal allograft.Semantic proximity Read ↗

Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Semantic proximity Read ↗

Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantationSemantic proximity Read ↗

Analysis of the donor-specific cytotoxic T-cell repertoire in a patient with a long-term surviving kidney allograft.Semantic proximity Read ↗

Immunological profile of patients awaiting a renal transplant.Semantic proximity Read ↗

Cytotoxic antibodies monitoring in kidney transplantation--their clinical relevance and challenges.Semantic proximity Read ↗

Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies.Semantic proximity Read ↗

Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations.Semantic proximity Read ↗

Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection.Semantic proximity Read ↗

Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review.Semantic proximity Read ↗

Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.